Literature DB >> 9185708

Identification of highly expressed genes in metastasis-suppressed chromosome 6/human malignant melanoma hybrid cells using subtractive hybridization and differential display.

J H Lee1, D R Welch.   

Abstract

Microcell-mediated transfer of chromosome 6 into human melanoma cell lines C8161 and MelJuSo suppresses metastasis by at least 95% without affecting tumorigenicity. Subtractive hybridization and differential display were used to identify the molecule(s) responsible for suppressing metastasis in neo6/melanoma (neo6/C8161 and neo6/MelJuSo) hybrids. Seven cDNA clones exhibiting quantitatively or qualitatively higher expression in neo6/melanoma hybrids were obtained. These genes fell into 2 categories: 1) transcription-related genes (AP-2A, HMG-I(Y) and a novel isoform of nucleophosmin B23), which have previously been shown to regulate metastasis-associated genes; and 2) novel genes. One of the novel genes, designated KiSS-1, significantly suppressed metastasis of the human malignant melanoma cell lines MelJuSo and a highly metastatic subclone of C8161, C8161cl.9, following transfection and constitutive expression. Our results illustrate the power of subtractive hybridization and differential display to identify functional metastasis-controlling genes in human melanoma.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9185708     DOI: 10.1002/(sici)1097-0215(19970611)71:6<1035::aid-ijc20>3.0.co;2-b

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  50 in total

Review 1.  International Union of Basic and Clinical Pharmacology. LXXVII. Kisspeptin receptor nomenclature, distribution, and function.

Authors:  Helen R Kirby; Janet J Maguire; William H Colledge; Anthony P Davenport
Journal:  Pharmacol Rev       Date:  2010-12       Impact factor: 25.468

Review 2.  Organizational and activational effects of sex steroids on kisspeptin neuron development.

Authors:  Matthew C Poling; Alexander S Kauffman
Journal:  Front Neuroendocrinol       Date:  2012-06-19       Impact factor: 8.606

Review 3.  KiSS-1 and GPR54 as new players in gonadotropin regulation and puberty.

Authors:  Ursula B Kaiser; Wendy Kuohung
Journal:  Endocrine       Date:  2005-04       Impact factor: 3.633

4.  KiSS-1 expression in human breast cancer.

Authors:  Tracey A Martin; Gareth Watkins; Wen G Jiang
Journal:  Clin Exp Metastasis       Date:  2005       Impact factor: 5.150

Review 5.  KISS1 in breast cancer progression and autophagy.

Authors:  Ilya V Ulasov; Anton V Borovjagin; Peter Timashev; Massimo Cristofanili; Danny R Welch
Journal:  Cancer Metastasis Rev       Date:  2019-09       Impact factor: 9.264

6.  The second genome: Effects of the mitochondrial genome on cancer progression.

Authors:  Adam D Scheid; Thomas C Beadnell; Danny R Welch
Journal:  Adv Cancer Res       Date:  2019-02-27       Impact factor: 6.242

Review 7.  G protein-coupled receptors involved in GnRH regulation: molecular insights from human disease.

Authors:  Sekoni D Noel; Ursula B Kaiser
Journal:  Mol Cell Endocrinol       Date:  2011-06-29       Impact factor: 4.102

8.  Clinical significance of KISS1 protein expression for brain invasion and metastasis.

Authors:  Ilya V Ulasov; Natalya V Kaverina; Peter Pytel; Bart Thaci; Feifei Liu; Douglas R Hurst; Danny R Welch; Husein A Sattar; Olufunmilayo I Olopade; Anatoly Y Baryshnikov; Zaira G Kadagidze; Maciej S Lesniak
Journal:  Cancer       Date:  2011-09-16       Impact factor: 6.860

9.  KISS1 methylation and expression as predictors of disease progression in colorectal cancer patients.

Authors:  Shao-Qin Chen; Zhi-Hua Chen; Su-Yong Lin; Qi-Bao Dai; Leng-Xi Fu; Rui-Qing Chen
Journal:  World J Gastroenterol       Date:  2014-08-07       Impact factor: 5.742

10.  KiSS1/GPR54 and estrogen-related gene expression profiles in primary breast cancer.

Authors:  Katarzyna Jarząbek; Leszek Kozłowski; Robert Milewski; Sławomir Wołczyński
Journal:  Oncol Lett       Date:  2012-01-26       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.